Skip to main content


That's why Save the Children and GSK joined forces in 2013. By bringing together our unique skills and resources, we are breaking new ground and finding new ways to reduce the number of children dying from preventable diseases.
GSK is a science-led global healthcare company and expert in the research, development and supply of medicines and vaccinations.

Together, we have reached over 2.8 million children under five and have addressed some of the main causes of preventable child deaths – including treating over 187,800 children for malaria, pneumonia, or diarrhoea. We have worked side by side in 45 countries, including our flagship programmes in Kenya and the Democratic Republic of Congo.

Together we are:

  • Researching and developing innovative child-friendly medicines to reduce child and infant deaths
  • Widening vaccination coverage to reduce the number of child deaths in the hardest to reach communities
  • Increasing investment in the training, reach and scope of health workers in the poorest communities to help reduce the number of children dying from preventable diseases
  • Helping children affected by disasters or humanitarian crises
  • Advocating at local and global levels for stronger child health policies

By joining forces and leading the way, we want to inspire organisations around the world to team up and join the fight against child mortality.

Together we can help build a world where no child under the age of five dies from preventable causes.

Child laughing

Want to hear more from us?

Find out how we're changing the lives of children – and how you can help.

You can unsubscribe at any time. Our email newsletter is administered by Save the Children US, whose privacy policy tells you more about how we use your information. Over 18s only.